المؤلفون: Chouik, Yasmina, Erard, Domitille, Demian, Hassan, Schulz, Thomas, Mazard, Tessa, Hartig-Lavie, Kerstin, Antonini, Teresa, Mabrut, Jean‐yves, Mohkam, Kayvan, Rode, Agnès, Merle, Philippe

المساهمون: Service d'Hépatologie Hôpital de la Croix-Rousse - HCL, Hôpital de la Croix-Rousse CHU - HCL, Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL)

المصدر: ISSN: 1664-3224.

مصطلحات موضوعية: immunotherapy, case-report, liver transplantation, Atezolizumab, complete response, Bevacizumab, hepatocellular carcinoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

العلاقة: hal-04161261; https://hal.science/hal-04161261Test; https://hal.science/hal-04161261/documentTest; https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

الإتاحة: https://doi.org/10.3389/fimmu.2023.1205997Test
https://hal.science/hal-04161261Test
https://hal.science/hal-04161261/documentTest
https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

المؤلفون: Chouik, Yasmina, Erard, Domitille, Demian, Hassan, Schulz, Thomas, Mazard, Tessa, Hartig-Lavie, Kerstin, Antonini, Teresa, Mabrut, Jean‐yves, Mohkam, Kayvan, Rode, Agnès, Merle, Philippe

المساهمون: Service d'Hépatologie Hôpital de la Croix-Rousse - HCL, Hôpital de la Croix-Rousse CHU - HCL, Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL)

المصدر: ISSN: 1664-3224.

مصطلحات موضوعية: immunotherapy, case-report, liver transplantation, Atezolizumab, complete response, Bevacizumab, hepatocellular carcinoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

العلاقة: hal-04161261; https://hal.science/hal-04161261Test; https://hal.science/hal-04161261/documentTest; https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

الإتاحة: https://doi.org/10.3389/fimmu.2023.1205997Test
https://hal.science/hal-04161261Test
https://hal.science/hal-04161261/documentTest
https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

المؤلفون: Chouik, Yasmina, Erard, Domitille, Demian, Hassan, Schulz, Thomas, Mazard, Tessa, Hartig-Lavie, Kerstin, Antonini, Teresa, Mabrut, Jean‐yves, Mohkam, Kayvan, Rode, Agnès, Merle, Philippe

المساهمون: Service d'Hépatologie Hôpital de la Croix-Rousse - HCL, Hôpital de la Croix-Rousse CHU - HCL, Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL)

المصدر: ISSN: 1664-3224.

مصطلحات موضوعية: immunotherapy, case-report, liver transplantation, Atezolizumab, complete response, Bevacizumab, hepatocellular carcinoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

العلاقة: hal-04161261; https://hal.science/hal-04161261Test; https://hal.science/hal-04161261/documentTest; https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

الإتاحة: https://doi.org/10.3389/fimmu.2023.1205997Test
https://hal.science/hal-04161261Test
https://hal.science/hal-04161261/documentTest
https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

المؤلفون: Chouik, Yasmina, Erard, Domitille, Demian, Hassan, Schulz, Thomas, Mazard, Tessa, Hartig-Lavie, Kerstin, Antonini, Teresa, Mabrut, Jean‐yves, Mohkam, Kayvan, Rode, Agnès, Merle, Philippe

المساهمون: Service d'Hépatologie Hôpital de la Croix-Rousse - HCL, Hôpital de la Croix-Rousse CHU - HCL, Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL)

المصدر: ISSN: 1664-3224.

مصطلحات موضوعية: immunotherapy, case-report, liver transplantation, Atezolizumab, complete response, Bevacizumab, hepatocellular carcinoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology

العلاقة: hal-04161261; https://hal.science/hal-04161261Test; https://hal.science/hal-04161261/documentTest; https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest

الإتاحة: https://doi.org/10.3389/fimmu.2023.1205997Test
https://hal.science/hal-04161261Test
https://hal.science/hal-04161261/documentTest
https://hal.science/hal-04161261/file/fimmu-14-1205997.pdfTest